News Makers of anticancer drugs are “profiteering,” say 100 specialists from around the world BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2810 (Published 30 April 2013) Cite this as: BMJ 2013;346:f2810 Article Related content Metrics Responses Peer review Related articles Editor's Choice Rx: A dose of ethics to revive trust in medical practice Published: 09 May 2013; BMJ 346 doi:10.1136/bmj.f2987 See more Breast cancer: Inaction on inequalities has led to unequal progress, say experts BMJ April 16, 2024, 385 q854; DOI: https://doi.org/10.1136/bmj.q854 Cancer: Fast tracked drugs often do not improve clinical outcomes, say researchers BMJ April 08, 2024, 385 q818; DOI: https://doi.org/10.1136/bmj.q818 NHS rolls out fast tracked immunotherapy for advanced endometrial cancer BMJ March 05, 2024, 384 q557; DOI: https://doi.org/10.1136/bmj.q557 Teledentistry may help in detecting oral cancers in current GP and dentist shortages BMJ March 01, 2024, 384 q512; DOI: https://doi.org/10.1136/bmj.q512 UK’s progress on cancer survival has slowed in past decade, figures show BMJ February 02, 2024, 384 q290; DOI: https://doi.org/10.1136/bmj.q290 Cited by... Conflict of interest among Italian medical oncologists: a national surveyAbstract Fulltext PDF
